28.12.2013 Views

LIVE POLIO IRUS VACCINES

LIVE POLIO IRUS VACCINES

LIVE POLIO IRUS VACCINES

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Capacity of Live Attenuated Polioviruses to Cause Human Infection 179<br />

prolonged periods, some lasting seven weeks.<br />

Poliovirus infections are shown by the black<br />

stripes. Coincidentally, many enterovirus infections<br />

were present and these are shown by various<br />

kinds of shaded stripes.<br />

And, as the final group in this series of diagrams<br />

the same general situation is shown for the<br />

67 exposed siblings within these same 48 families<br />

(see Figures 7 and 8).<br />

Figure 7 illustrates Type 1 infections in the<br />

population of 67 siblings (under the age of five)<br />

who were members of those families in which intrafamilial<br />

exposure to an infected vaccinee occurred.<br />

Fifteen siblings possessed Type 1 poliovirus<br />

antibodies prior to the administration of<br />

the first dose of triple vaccine. Eleven negative<br />

siblings converted during the 9-week-period of<br />

observation-a rate of 21 per cent. Of those 15<br />

children already possessing antibodies to Type<br />

1, 5 showed a fourfold rise associated with reinfection<br />

as indicated by the dark area in the<br />

lower right-hand corner.<br />

Figure 8 similarly illustrates Type 3 infec-<br />

; lPE lil: XIst Va~cv · <<br />

tions among 67 siblings as a result of intrafamilial<br />

exposure. Forty of these siblings<br />

possessed antibodies to Type 3 poliovirus before<br />

vaccine was introduced into the family, and of<br />

these, 18 became re-infected. Of those 27 who<br />

lacked antibodies at the onset, 15 converted.<br />

Non-poliovirus Enteroviruses. The degree to<br />

which the children in this study were harboring<br />

non-poliovirus enteroviruses during the prevaccinal<br />

period of one week appears in Fig. 9.<br />

In Figure 9 the age-specific rates are shown<br />

at which participants in this trial excreted polioviruses<br />

and non-poliovirus enteroviruses prior to<br />

the first administration of vaccine. Our impression<br />

is that the impact of the non-poliovirus enteroviruses<br />

upon the poliovirus responses in the<br />

vaccinees, or the actual degree of interference<br />

which they exerted in this trial was appreciable<br />

but not great. When a comparative rate analysis<br />

was made to determine whether those children<br />

harboring such enteroviruses at the beginning of<br />

the trial had a higher failure rate than tlihose without<br />

enteroviruses, there was evidence that, as far<br />

2nd Vac.<br />

Siblings<br />

=<br />

__<br />

#J t<br />

FIG. 8

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!